If you invested in Organon and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses »
CLASS PERIOD
N/A
LEAD PLAINTIFF DEADLINE
N/A
STOCK SYMBOL
NYSE: OGN
CONTACT
844-916-0895
[email protected]
In the past, Organon has repeatedly assured investors that it maintained effective internal control over financial reporting and that its financial statements conformed with applicable accounting rules.
These assurances came into question on October 27, 2025, when the Organon filed its current report revealing “[a]fter concerns regarding the Company’s wholesaler sales practices for its NexplanonÒ product were brought to the Board’s attention, the Audit Committee of the Board oversaw an independent, internal investigation into sales to wholesalers.”
Organon further revealed that “[t]he investigation found that certain wholesalers in the United States were asked to buy more Nexplanon than they needed at the end of the fourth quarter of 2022, the third and fourth quarters of 2024 and the first, second and third quarters of 2025[]” and that “these sales practices […] enabled Organon to meet guidance and/or certain external revenue expectations.”
Accordingly, the company fired its Head of U.S. Commercial & Government Affairs and CEO Ali resigned without severance or equity-related retirement benefits.
FREQUENTLY ASKED QUESTIONS ABOUT THE CASE
- What is the OGN investigation about?
-
We are focused on investors’ losses and the extent to which Organon may have engaged in improper channel stuffing.
WHAT SHOULD I DO?
- I worked at OGN. What should I do?
-
If you were an employee of OGN, you may have valuable information that could be relevant to the investigation. Hagens Berman is one of the nation’s top whistleblower law firms, and has successfully represented many individuals who come forward with information regarding corporate malfeasance. Under the new SEC Whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, contact Reed Kathrein at 844-916-0895 or [email protected].
- There are multiple law firms participating, do I need to contact all of them?
-
No, you do not need to contact all participating law firms. Generally, class-action investigations and lawsuits are consolidated into a single case to streamline the legal process, and attorneys from only a few law firms are selected to serve in a leadership role on the consolidated case. Hagens Berman has a proven track record of being appointed to leadership roles in complex, multidistrict litigation regarding investor fraud and other consumer rights issues, and your claim will be handled by attorneys who have helped secure approximately $325 billion in class-action settlements on behalf of individuals who have suffered due to corporate malfeasance and the wrongdoing of other powerful institutions.
AM I ELIGIBLE?
- What is the threshold amount to be eligible? What are “substantial” losses?
-
The threshold amount and the definition of "substantial" losses may vary depending on a number of factors specific to the case, including the size of the company, market cap, shares outstanding and who holds them and the damages alleged by the fraud. In general, to be eligible to participate in a class-action lawsuit, you must be able to demonstrate that you suffered financial losses as a result of the alleged wrongdoing and that your losses meet the criteria set by the court or law firm. Fill out the form and submit your losses.
CAN I PARTICIPATE?
- Am I affected? What do I need to do to participate?
-
If you were an investor in OGN, you may be affected and eligible to participate in the case. To determine your eligibility and potential involvement, fill out the form and submit your losses.
- Can any OGN investor participate?
-
In most class-action investigations and cases, any investor who meets the eligibility criteria, including purchasing the shares during the relevant period, can participate, regardless of the size of their investment. Fill out the form to find out your rights.
- I bought on a non-U.S. Exchange. Can I participate?
-
No. This investigation only covers shares bought on a U.S. exchange, i.e. NASDAQ or NYSE. Fill out the form to find out your rights.
- Am I included if I still hold my shares, or do I need to sell to participate?
-
Participation is based on purchasing shares during the relevant period, rather than your current holdings. Accordingly, you do not need to sell to participate. Fill out the form to find out your rights.





